Concentrix Corporation
CNXC
$47.10
$2.475.53%
11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
---|---|---|---|---|---|
Revenue | 9.62B | 9.40B | 8.65B | 7.88B | 7.11B |
Total Other Revenue | -- | 524.48M | 886.72M | 1.27B | 1.65B |
Total Revenue | 9.62B | 9.40B | 8.65B | 7.88B | 7.11B |
Cost of Revenue | 6.17B | 6.00B | 5.52B | 5.03B | 4.54B |
Gross Profit | 3.45B | 3.40B | 3.13B | 2.85B | 2.58B |
SG&A Expenses | 2.24B | 2.42B | 2.16B | 1.90B | 1.63B |
Depreciation & Amortization | 458.93M | 214.83M | 214.83M | 214.83M | 214.83M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 8.87B | 8.64B | 7.89B | 7.14B | 6.39B |
Operating Income | 746.09M | 761.56M | 753.26M | 743.19M | 728.27M |
Income Before Tax | 299.27M | 263.48M | 343.87M | 362.71M | 408.23M |
Income Tax Expenses | 48.06M | 58.42M | 77.81M | 84.64M | 94.39M |
Earnings from Continuing Operations | 251.22 | 205.05 | 266.06 | 278.07 | 313.84 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 251.22M | 205.05M | 266.06M | 278.07M | 313.84M |
EBIT | 746.09M | 761.56M | 753.26M | 743.19M | 728.27M |
EBITDA | 1.45B | 1.45B | 1.35B | 1.24B | 1.12B |
EPS Basic | 3.72 | 3.09 | 4.34 | 4.87 | 5.79 |
Normalized Basic EPS | 4.11 | 3.69 | 4.72 | 5.33 | 6.01 |
EPS Diluted | 3.72 | 3.09 | 4.33 | 4.85 | 5.77 |
Normalized Diluted EPS | 4.11 | 3.69 | 4.71 | 5.31 | 5.98 |
Average Basic Shares Outstanding | 259.91M | 257.44M | 243.84M | 229.75M | 215.24M |
Average Diluted Shares Outstanding | 260.23M | 257.83M | 244.29M | 230.35M | 216.03M |
Dividend Per Share | 1.24 | 1.21 | 1.18 | 1.16 | 1.13 |
Payout Ratio | 33.36% | 39.89% | 28.50% | 25.10% | 20.23% |